This article has expired, however you can still
download the PDF
STOCKHOLM, October 4, 2013 /PRNewswire/ --
Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces it has raised SEK96 million (€11m / US$15m) in a Series C financing round. The round was co-led by two of the ...